Long-term administration of l-3, 4-dihydroxyphenylalanine (levodopa), the mainstay
treatment for Parkinson's disease (PD), is accompanied by fluctuations in its duration of …

Abstract Tetrabromobisphenol A (2, 2-bis (4-hydroxy-3, 5-dibromophenyl) propane; TBBPA)
is a widely used brominated flame retardant. TBBPA induces neuronal damage, but the …

A dysregulated response of the neuroimmune system is a main contributor to the
progression of neurodegeneration in Parkinson's disease (PD). Recent findings suggest that …

Rationale Previously, we showed that pioglitazone exerts its antidepressant-like effect
through peroxisome proliferator-activated receptor gamma receptors and demonstrated the …

It has become increasingly clear that environmental chemicals have the capability of
impacting endocrine function. Moreover, these endocrine disrupting chemicals (EDCs) have …

The molecular mechanisms controlling the specification of neural cell fates have been the
focus of intense research in recent years. Neural precursor cells (NPCs) sequentially …

Background and Purpose: Studies in the animals suggested that Peroxisome proliferators
activated receptors (PPARs) may be involved in seizure control and selective agonists of …

Existing experimental evidence suggests that PPARγ may play a beneficial role in
neuroprotection from various brain pathologies. Here we found that focal cerebral ischemia …

Background Megalin is a large endocytic receptor with relevant functions during
development and adult life. It is expressed at the apical surface of several epithelial cell …

Epidermal fatty acid‐binding protein (E‐FABP), a member of the family of FABPs, exhibits a
robust expression in neurons during axonal growth in development and in nerve …